Elevated FTO level in AML cells suppresses the m6A abundance and stability of ankyrin repeat and SOCS box‐containing 2 (ASB2) and retinoic acid receptor alpha (RARA) mRNA. The gene discussed is RARA; the disease is acute myeloid leukemia.